HIV / AIDS in the News

๐—ž๐—ถ๐˜€๐˜‚๐—บ๐˜‚ ๐—น๐—ฎ๐˜‚๐—ป๐—ฐ๐—ต ๐—›๐—œ๐—ฉ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐—ฑ๐—ฟ๐˜‚๐—ด Kisumu residents will now access a new long-acting HIV prevention drug administered only twice a year after the county launched the rollout of Lenacapavir, marking a major shift in efforts to curb infections in -โ€ฆ

 

Yeztugo Targets HIV Prevention To Broad Audience 03/09/2026 - MediaPost

 

2. Nigeria: Living with HIV - EL PAรS English

 

โ€˜Unitedโ€™: 2026 Dance Marathon kicks off to raise awareness for pediatric AIDS - Daily Bruin

 

NEARLY 20,000 people tested positive for human immunodeficiency virus (HIV) in 2025, with a monthly average of over 1,600 new cases. - facebook.com

 

Gileadโ€™s BIC LEN HIV Results Highlight Valuation Gap And Future Potential - Yahoo Finance

 

Integrity House kiosk in Newark offers naloxone, HIV tests - NJBIZ

 

New HIV-1 Lenacapavir Resistance Paths Revealed - Bioengineer.org

 

Quality-of-Life Outcomes in People With HIV After Cancer Diagnosis โ€“ SIOG - Oncodaily

 

Tens of thousands of Americans are losing access to treatment for HIV as nearly 20 states impose restrictions on assistance programs and several others weigh such changes. - facebook.com

 

Will HIV cases spread as state cuts jeopardize access to drugs? - USA Today

 

South Africa Pushes for Local Manufacturing of Breakthrough HIV Prevention Drug - Fine Day 102.3

 

HIV-seq tool finds active reservoir cells during therapy - Medical Xpress

 

[CROI 2026] Healio: Tecovirimat lacks potency against mpox, more studies show - European AIDS Treatment Group

 

[CROI 2026] Medscape: PIP matches PrEP for low-risk HIV - European AIDS Treatment Group

 

[CROI 2026] POZ: Doravirine/islatravir combo pill could soon be a new HIV treatment option - European AIDS Treatment Group

 

[CROI 2026] aidsmap: Multi-component app improves viral suppression in men who use crystal meth - European AIDS Treatment Group

 

[CROI 2026] aidsmap: African paediatric studies at CROI: HIV remission in children, three bNAbs in babies, two years on injectables in teens - European AIDS Treatment Group

 

[CROI 2026] aidsmap: Immune modulator N-803 does not control HIV rebound, suggesting a combination approach is needed for a functional cure - European AIDS Treatment Group

 

[CROI 2026] aidsmap: New antiretrovirals in the pipeline could be part of twice-yearly HIV treatment - European AIDS Treatment Group

 

New JIAS viewpoint for International Womenโ€™s Day: Navigating the data gaps of ageing among women living with HIV - European AIDS Treatment Group

 

UNAIDS: International Womenโ€™s Day: Rights, justice, and action for women and girls - European AIDS Treatment Group

 

[Press release] Scripps Research Institute: Nanoparticle vaccine approach takes on a new target: Hepatitis C virus - European AIDS Treatment Group

 

Healio: Positive HIV status may increase risk for poor postoperative total joint arthroplasty outcomes - European AIDS Treatment Group

 

IrsiCaixa: An HIV treatment succeeds in restoring the microbiome in advanced stages of infection - European AIDS Treatment Group

 

Phase 3 Trial Tests an Integrase Inhibitorโ€“Free, Tenofovir-Free First-Line HIV Regimen - Patient Care Online

 

[Press release] Gladstone Institutes: New tool reveals the secrets of HIV-infected cells - European AIDS Treatment Group

 

Confronting the unequal burden of HIV and AIDS on women of color: Equity cannot wait - Gay City News

 

Dallas has one of the highest HIV rates in Texas. Three nonprofits received grants to fight that - KERA News

 

Rapid-Repeat Pregnancy and HIV Vulnerability: Elona Toska, MSc, DPhil - AJMC